GO:0031440 regulation of mRNA 3'-end processing: RNA Processing Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031440 (regulation of mRNA 3'-end processing) describes any process that modulates the frequency, rate or extent of the cleavage and polyadenylation reactions that form the mature 3' end of an mRNA molecule.
• mRNA 3'-end processing is executed by a large multi-protein machinery that recognizes the polyadenylation signal, cleaves the pre-mRNA, and adds the poly(A) tail.
• Regulation occurs at multiple levels, including recruitment of processing factors to RNA polymerase II, sequence elements in the pre-mRNA, and post-translational modification of processing proteins.
• The process is co-transcriptional and functionally coupled to transcription termination, splicing, and RNA modification, so its regulation influences gene expression broadly.
• Dysregulation of 3'-end processing is linked to cancer, viral infection, and developmental disorders, making its regulators attractive research and therapeutic targets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate regulators of mRNA 3'-end processing.
Description
Regulation of mRNA 3'-end processing (GO:0031440) is the biological process that controls how often, how fast, and to what extent a pre-mRNA molecule receives its mature 3' end. The core reaction involves endonucleolytic cleavage of the nascent transcript at the polyadenylation site followed by addition of a poly(A) tail, and this reaction is carried out by a conserved multi-subunit machinery. Because almost every eukaryotic mRNA must undergo this step to become translatable and stable, the regulation of 3'-end processing sits at a central node of gene expression control. Researchers study GO:0031440 because changes in the efficiency or site choice of 3'-end processing can alter transcript stability, coding potential, and protein output. Regulatory inputs include the recruitment of processing factors to the C-terminal domain of RNA polymerase II, cis-acting sequence elements in the pre-mRNA, and post-translational modifications of the processing machinery. The process is also physically and functionally coupled to transcription termination and splicing, so its regulation is embedded in the broader co-transcriptional RNA processing network. From a disease perspective, altered regulation of 3'-end processing has been observed in virus-infected cells and in cancer, where changes in polyadenylation site usage can produce oncogenic isoforms or stabilize transcripts. This makes the regulators of GO:0031440 important candidates for functional genomics and for therapeutic intervention.
regulation of mRNA 3'-end processing At A Glance
| GO ID | GO:0031440 |
|---|---|
| GO term | regulation of mRNA 3'-end processing |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of cleavage and polyadenylation that generate the mature 3' end of mRNA |
| Biological context | Co-transcriptional RNA processing coupled to transcription termination and splicing |
| Key machinery | Cleavage and polyadenylation factors, poly(A) polymerases, and 3' end nucleases |
| Disease relevance | Cancer, viral infection, and developmental disorders |
| Research methods | RNA-seq, 3' end sequencing, CRISPR knockout and knock-in models |
What Is GO:0031440?
GO:0031440, regulation of mRNA 3'-end processing, is defined as any process that modulates the frequency, rate or extent of mRNA 3'-end processing, which is itself any process involved in forming the mature 3' end of an mRNA molecule. In practice, this means the collection of molecular events that control when, where, and how efficiently the pre-mRNA is cleaved and polyadenylated.
Why Is regulation of mRNA 3'-end processing Important in Cell Biology?
Regulation of mRNA 3'-end processing is important because it determines the fate of nearly every mRNA in the cell. By controlling cleavage site choice and poly(A) tail addition, this process influences transcript stability, nuclear export, and translation efficiency, and it is tightly coupled to transcription termination. Consequently, perturbations in GO:0031440 can reshape the transcriptome and contribute to disease, including cancer and viral pathogenesis.
• Controls the formation of the mature 3' end required for mRNA stability and translation.
• Determines alternative polyadenylation site usage, which can change coding potential and regulatory element content.
• Is functionally coupled to transcription termination by RNA polymerase II.
• Influences co-transcriptional splicing and RNA modification events.
• Is hijacked or modulated during viral infection to favor viral gene expression.
• Is dysregulated in cancer, where altered 3' end processing can stabilize oncogenic transcripts.
• Provides targets for therapeutic intervention through the mRNA 3' end nuclease and associated factors.
• Can be studied systematically using CRISPR-based functional genomics.
What Happens During regulation of mRNA 3'-end processing?
Recognition of the polyadenylation signal
In simple terms: The cell first reads a short sequence near the end of the RNA to know where to cut.
Regulation begins with recognition of cis-acting elements in the pre-mRNA, most notably the polyadenylation signal, by cleavage and polyadenylation specificity factor (CPSF) and associated proteins. The efficiency of this recognition step is a major point of regulation and can be influenced by sequence variants and RNA-binding proteins. This step ensures that cleavage occurs at the correct position and is a prerequisite for subsequent poly(A) addition.
Cleavage of the pre-mRNA
In simple terms: A molecular scissors cuts the RNA at the chosen site.
After signal recognition, the cleavage factor machinery, including cleavage stimulation factor (CSTF) and cleavage factor I/II (CFI/CFII), positions the endonuclease to cut the pre-mRNA. The mRNA 3' end nuclease is a key catalytic component whose activity and recruitment are regulated. Cleavage generates a free 3' hydroxyl that serves as the substrate for poly(A) polymerase.
Poly(A) tail addition
In simple terms: A string of A's is added to the cut end to protect and stabilize the RNA.
Poly(A) polymerase adds a poly(A) tail to the newly cleaved 3' end, with the initial addition stimulated by CPSF and the poly(A) binding protein PABPN1. The length and rate of tail addition are regulated and influence mRNA stability and translation. This step completes the formation of the mature 3' end.
Coupling to transcription and splicing
In simple terms: The cutting and tailing happen while the RNA is still being made, and they talk to other RNA processing steps.
3'-end processing is co-transcriptional and physically linked to the C-terminal domain of RNA polymerase II, which recruits processing factors. This coupling coordinates cleavage and polyadenylation with transcription termination and with splicing, so regulation of 3'-end processing can affect multiple steps of gene expression. RNA modifications such as pseudouridylation can also influence this co-transcriptional network.
Regulatory inputs and feedback
In simple terms: Many signals tell the machinery to speed up, slow down, or choose a different cut site.
Regulation of GO:0031440 integrates multiple inputs, including the concentration and modification state of processing factors, the availability of RNA-binding proteins, and signals from transcription. For example, post-translational modifications and developmental or viral cues can alter processing efficiency and site choice. These inputs allow the cell to tune 3' end formation in response to physiological and pathological conditions.
Key Genes Involved in GO:0031440 regulation of mRNA 3'-end processing
The genes and proteins below are core components or regulators of mRNA 3'-end processing and are frequently studied in the context of GO:0031440.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CPSF1 | Core subunit of cleavage and polyadenylation specificity factor | Required for polyadenylation signal recognition and cleavage |
| CPSF2 | Subunit of CPSF complex | Supports cleavage and polyadenylation activity |
| CPSF3 | Endonuclease subunit of CPSF | Catalytic cleavage of pre-mRNA at poly(A) site |
| CPSF4 | Subunit of CPSF complex | Contributes to processing complex assembly |
| CSTF1 | Subunit of cleavage stimulation factor | Stimulates cleavage and polyadenylation |
| CSTF2 | RNA-binding subunit of CSTF | Recognizes downstream sequence elements |
| CSTF3 | Subunit of CSTF | Stabilizes CSTF complex on RNA |
| CFI | Cleavage factor I complex | Assists in cleavage site selection |
| CFII | Cleavage factor II complex | Required for efficient cleavage |
| PAPOLA | Canonical poly(A) polymerase | Adds poly(A) tail to cleaved mRNA |
| PABPN1 | Nuclear poly(A) binding protein | Controls poly(A) tail length and stability |
| SYMPK | Symplekin, scaffold protein | Coordinates processing complex assembly |
| WDR33 | CPSF subunit | Recognizes polyadenylation signal |
| FIP1L1 | CPSF subunit | Links CPSF to poly(A) polymerase |
| CLP1 | RNA kinase in tRNA splicing and mRNA processing | Modulates processing factor function |
| CPSF6 | CPSF subunit | Influences alternative polyadenylation |
| NUDT21 | CPSF subunit | Regulates alternative polyadenylation site choice |
How Is regulation of mRNA 3'-end processing Regulated?
Regulation of mRNA 3'-end processing is itself controlled by multiple mechanisms. The recruitment of processing factors to the phosphorylated C-terminal domain of RNA polymerase II provides a major layer of control, linking the rate of transcription to the efficiency of 3' end formation. Post-translational modifications of processing proteins and the availability of RNA-binding proteins further modulate activity and site choice. In virus-infected cells, viral proteins and RNA elements can reprogram the host 3'-end processing machinery to favor viral transcripts. Additionally, co-transcriptional RNA modifications such as pseudouridylation can influence pre-mRNA processing, including 3' end formation.
regulation of mRNA 3'-end processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CPSF3 | Cancer, altered polyadenylation | Knockout or point-mutation cell lines |
| NUDT21 | Cancer, alternative polyadenylation | Overexpression and knockout models |
| CPSF6 | Cancer, viral infection | Knock-in of tagged alleles |
| PABPN1 | Muscle and neurological disorders | Knock-in of disease-associated mutations |
| CSTF2 | Cancer, developmental defects | CRISPR knockout and rescue |
Cancer and alternative polyadenylation
Alterations in the regulation of mRNA 3'-end processing can lead to changes in polyadenylation site usage, producing mRNA isoforms with different stability or coding potential. Such changes have been implicated in cancer, where they can affect oncogene expression and tumor progression. The mRNA 3' end nuclease and its regulators are therefore considered potential therapeutic targets.
Viral infection and host machinery modulation
Viruses often modulate host mRNA 3'-end processing and transcription termination to enhance viral gene expression and evade host defenses. This makes GO:0031440 a relevant area for understanding viral pathogenesis and for developing antiviral strategies.
Developmental and neurological disorders
Because 3'-end processing is essential for gene expression, mutations in core processing factors can disrupt development. While specific disorders vary, the general principle is that impaired regulation of 3' end formation can contribute to developmental and neurological phenotypes.
From regulation of mRNA 3'-end processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for 3'-end processing? | CRISPR knockout cell line |
| Does a specific mutation alter processing efficiency? | Point-mutation knock-in |
| Where does a processing factor localize? | Tagged knock-in (e.g., GFP) |
| Does overexpression change polyadenylation site choice? | Overexpression cell model |
| Which regulators affect global 3' end formation? | CRISPR library screening |
| How does viral infection modulate host processing? | Infection of knockout or overexpression cells |
How to Study the regulation of mRNA 3'-end processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript levels and isoforms | Detect changes in 3' end processing |
| 3' end sequencing | Polyadenylation site usage | Map alternative poly(A) sites |
| CRISPR knockout | Loss-of-function effects | Test requirement of candidate regulators |
| CRISPR library screen | Phenotypes across many genes | Discover new regulators |
| In vitro cleavage assay | Cleavage efficiency | Study mechanism of processing factors |
| Structural biology | Protein-RNA interactions | Define assembly of processing complex |
| Imaging | Subcellular localization | Track processing factors in cells |
RNA-seq and 3' end sequencing
RNA sequencing, especially 3' end-focused protocols, can map polyadenylation sites and quantify changes in 3' end processing across the transcriptome. These methods are central to studying regulation of mRNA 3'-end processing and alternative polyadenylation.
CRISPR functional genomics
CRISPR knockout and library screening allow systematic testing of which genes regulate 3' end processing. Pooled screens coupled to 3' end readouts can identify novel regulators.
Biochemical and structural approaches
In vitro cleavage and polyadenylation assays, combined with structural studies, reveal how processing factors assemble and function. Such work has defined the mechanistic basis of regulation.
Imaging and co-transcriptional assays
Live-cell imaging and co-transcriptional labeling can show when and where processing occurs relative to transcription. These approaches help dissect the coupling between transcription and 3' end formation.
How CRISPR Can Be Used to Study GO:0031440 regulation of mRNA 3'-end processing
Knockout
CRISPR knockout of candidate genes is used to test whether a factor is required for mRNA 3'-end processing. Loss of core processing genes often impairs cell viability, so inducible or conditional systems may be needed.
Point Mutation
Point mutations can be introduced to dissect specific domains or residues of processing factors, such as catalytic residues of the 3' end nuclease. This allows separation of enzymatic activity from scaffolding functions.
Knock-in
Knock-in of tags or disease-associated alleles enables tracking of endogenous proteins and study of pathogenic variants in a physiological context. Tagged knock-ins are useful for localization and interaction studies.
Overexpression
Overexpression models can reveal gain-of-function effects and are particularly useful for studying how increased levels of a processing factor alter polyadenylation site choice and gene expression.
How EDITGENE Supports regulation of mRNA 3'-end processing Research
Researchers studying regulation of mRNA 3'-end processing-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. CRISPR-based models provide the causal evidence required for publication and translational follow-up.
Contact EDITGENE today to design your custom CRISPR model for regulation of mRNA 3'-end processing research.
Frequently Asked Questions About regulation of mRNA 3'-end processing
What is GO:0031440?
GO:0031440 is the Gene Ontology term for regulation of mRNA 3'-end processing, defined as any process that modulates the frequency, rate or extent of forming the mature 3' end of an mRNA molecule.
What is mRNA 3'-end processing?
It is the cleavage and polyadenylation of a pre-mRNA that generates a mature 3' end, a step required for mRNA stability and translation.
What genes are involved in regulation of mRNA 3'-end processing?
Key genes include CPSF subunits (CPSF1-4, CPSF6, WDR33, FIP1L1, NUDT21), CSTF subunits, CFI/CFII, PAPOLA, and PABPN1.
How is mRNA 3'-end processing regulated?
It is regulated by recruitment of processing factors to RNA polymerase II, cis-acting RNA elements, post-translational modifications, and coupling to transcription and splicing.
Why is regulation of mRNA 3'-end processing important in cancer?
Altered regulation can change polyadenylation site usage and stabilize oncogenic transcripts, making it a therapeutic target.
How do viruses affect mRNA 3'-end processing?
Viruses can modulate host 3'-end processing and transcription termination to favor viral gene expression.
What methods are used to study GO:0031440?
RNA-seq, 3' end sequencing, CRISPR knockout and screens, in vitro cleavage assays, and structural biology are commonly used.
Can CRISPR be used to study mRNA 3'-end processing?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of processing regulators.
What is alternative polyadenylation?
It is the use of different polyadenylation sites in a transcript, producing mRNA isoforms with different 3' ends, and it is a key output of regulated 3' end processing.
Is regulation of mRNA 3'-end processing co-transcriptional?
Yes, it occurs co-transcriptionally and is coupled to transcription termination and splicing.
Conclusion
GO:0031440, regulation of mRNA 3'-end processing, is a central biological process that controls the formation of mature mRNA 3' ends. Its regulation integrates transcription, RNA sequence elements, and protein modifications, and it is coupled to splicing and termination. Dysregulation of this process is linked to cancer and viral infection, underscoring its importance as a research and therapeutic target. CRISPR-based models, including knockout, point-mutation, knock-in, and overexpression, provide powerful tools to dissect the causal roles of processing regulators. Combined with RNA-seq and 3' end sequencing, these approaches enable rigorous functional studies of GO:0031440.
References
- 1. Boreikaitė V et al.. 2023. 3'-End Processing of Eukaryotic mRNA: Machinery, Regulation, and Impact on Gene Expression.. Annu Rev Biochem 92:199-225 PMID: 37001138
- 2. Vijayakumar A et al.. 2022. Modulation of mRNA 3'-End Processing and Transcription Termination in Virus-Infected Cells.. Front Immunol 13:828665 PMID: 35222412
- 3. Millevoi S et al.. 2010. Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation.. Nucleic Acids Res 38(9):2757-74 PMID: 20044349
- 4. Carrocci TJ et al.. 2024. Emerging and re-emerging themes in co-transcriptional pre-mRNA splicing.. Mol Cell 84(19):3656-3666 PMID: 39366353
- 5. Wahle E et al.. 1999. 3'-End processing of pre-mRNA in eukaryotes.. FEMS Microbiol Rev 23(3):277-95 PMID: 10371034
- 6. Martinez NM et al.. 2022. Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing.. Mol Cell 82(3):645-659.e9 PMID: 35051350
- 7. Kumar A et al.. 2019. Mechanistic insights into mRNA 3'-end processing.. Curr Opin Struct Biol 59:143-150 PMID: 31499460
- 8. Liu H et al.. 2021. On the Cutting Edge: Regulation and Therapeutic Potential of the mRNA 3' End Nuclease.. Trends Biochem Sci 46(9):772-784 PMID: 33941430
